Sarah and the GIP Paradox: Gastric inhibitory polypeptide
Case Study: Sarah, a 45-year-old woman, has lived with type 2 diabetes for five years. Despite medication and dietary changes, her blood sugar control remains erratic. Her doctor suspects the GIP paradox could be playing a role. The Good: After meals, Sarah’s insulin levels rise appropriately thanks to GIP, initially helping lower her blood sugar. … Continue reading Sarah and the GIP Paradox: Gastric inhibitory polypeptide
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed